Table 6.

National cost projections for all cancer sites combined through 2030 by sex using different scenarios for projections of incidence and survival. National costs for medical services (Medicare Parts A and B), oral prescription drugs (Medicare Part D) and total costs (Medicare Parts A, B, and D) by sex. Percent increase from 2015. Costs are in 2019 Billion dollars.

		National Costs in 2019 Billion Dollars
		Medical Services (Part A &B)					Precription Drug (Part D)					Parts (A, B & D)
Sex	Trend scenario*	2015	2020	2025	2030	Increas e2015 to 2030	2015	2020	2025	2030	Increase 2015 to 2030	2015	2020	2025	2030	Increase 2015 to 2030
Males	Base	$78	$86	$96	$105	35%	$8	$9	$10	$12	40%	$86	$95	$106	$117	35%
Males	Inc.	$78	$85	$89	$92	18%	$8	$9	$10	$10	25%	$86	$94	$99	$102	18%
Males	Inc.+Surv.	$78	$86	$91	$95	22%	$8	$9	$10	$11	33%	$87	$95	$101	$106	23%
Females	Base	$87	$95	$104	$116	33%	$10	$11	$12	$13	39%	$96	$105	$116	$129	34%
Females	Inc.	$88	$98	$108	$118	34%	$10	$11	$12	$13	39%	$98	$109	$120	$131	34%
Females	Inc.+Surv.	$88	$98	$108	$119	35%	$10	$11	$12	$14	43%	$98	$109	$120	$133	36%
Both	Base	$165	$181	$200	$221	34%	$18	$20	$22	$25	40%	$183	$201	$222	$246	34%
Both	Inc.	$166	$183	$197	$210	26%	$18	$20	$22	$24	32%	$184	$203	$219	$234	27%
Both	Inc.+Surv.	$166	$183	$199	$214	29%	$18	$20	$23	$25	38%	$184	$204	$222	$239	30%

^*All scenarios include the aging and growth of the US population: Base= incidence and survival constant as observed in last years of data; Inc= Future trends of incidence and constant survival; and Inc.+Surv.= Future trends of incidence and survival.